Catalyst Wire Dossier Catalyst Wire Dossier

SARS-CoV-2 modRNA vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SARS-CoV-2 modRNA vaccine, covering 2024-05-17 to 2024-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) [Phase 4]

See pricing